嘉实上证科创板生物医药ETF发起联接A(021060)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
260,723.50 |
141,119.38 |
196,920.37 |
| 存出保证金 |
39,685.98 |
141,656.32 |
27,486.25 |
| 交易性金融资产 |
79,240,278.50 |
40,227,684.89 |
46,270,700.46 |
| 其中：股票投资 |
836,620.40 |
1,319,027.29 |
927,800.46 |
| 债券投资 |
606,057.86 |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
1,460,786.10 |
409,903.59 |
428,205.08 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
85,441,441.68 |
43,370,032.53 |
49,720,646.75 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
842,426.09 |
- |
445,747.82 |
| 应付赎回款 |
1,425,034.69 |
653,949.78 |
285,820.58 |
| 应付管理人报酬 |
2,304.57 |
1,560.69 |
1,613.40 |
| 应付托管费 |
460.92 |
312.13 |
322.69 |
| 应付销售服务费 |
11,746.68 |
5,012.64 |
7,378.64 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
20,328.20 |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
102,346.72 |
54,430.41 |
94,848.08 |
| 负债合计 |
2,384,319.67 |
735,593.85 |
835,731.21 |
| 所有者权益 |
| 实收基金 |
71,409,052.18 |
37,404,036.66 |
50,130,757.07 |
| 未分配利润 |
11,648,069.83 |
5,230,402.02 |
-1,245,841.53 |
| 所有者权益合计 |
83,057,122.01 |
42,634,438.68 |
48,884,915.54 |
| 负债及所有者权益总计 |
85,441,441.68 |
43,370,032.53 |
49,720,646.75 |
微信公众号
证券之星APP
基本资料
